Unlike inhibitory receptors present on NKT-like cells, which recognize MHC-I/MHC-like molecules, activating receptors (such as NKp30 and NKG2D) recognize ligands on the altered cells (tumor cells, virus-infected cells). Here, NCR3 is linked to neoplasm.